Literature DB >> 21507039

Noncultured epidermal suspension transplantation for the treatment of stable vitiligo in children and adolescents.

K Sahni1, D Parsad, A J Kanwar.   

Abstract

BACKGROUND: Surgery is a well-established treatment for stable vitiligo in adults. However, there are few studies to date reporting the use of surgery in children and adolescents. AIM: To assess the efficacy and safety of transplantation of autologous noncultured epidermal suspension for the treatment of stable vitiligo in children and adolescents.
METHODS: Noncultured epidermal suspension transplantation was performed in 13 children and adolescents (age 8-17 years), with a total of 19 lesions of stable vitiligo. Patients were followed up for at least 1 year. Results were assessed for degree of repigmentation, colour match compared with normal skin, and adverse events.
RESULTS: Of the 19 lesions, 15 (79%) had > 90% repigmentation at the end of 1 year, and the remaining 4 lesions (21%) had 75-90% repigmentation. Results were not influenced by age, gender, site or size of lesions, type of vitiligo, or duration of stability of disease, although the small sample size makes conclusions tentative. The colour match at the final visit was excellent for 16 of the 19 lesions (84.2%). No major adverse effects were seen except for infection at the recipient site in one patient.
CONCLUSION: Transplantation of noncultured epidermal suspension is a safe and effective treatment for stable vitiligo in childhood. Considering its good efficacy and safety as a day-care procedure under local anaesthesia, it may be considered one of the treatments of choice for stable vitiligo in children and adolescents, especially for cases resistant to other therapies. © The Author(s). CED
© 2011 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2011        PMID: 21507039     DOI: 10.1111/j.1365-2230.2011.04065.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  7 in total

1.  The clinical experience for treating post-burn depigmentation with tiny epidermal particles graft.

Authors:  Baoguo Chen; Minghuo Xu; Bingyuan Li
Journal:  Int Wound J       Date:  2016-03-10       Impact factor: 3.315

2.  Amniotic membrane as a scaffold for melanocyte transplantation in patients with stable vitiligo.

Authors:  Pedro Redondo; Ana Giménez de Azcarate; Laura Marqués; María García-Guzman; Enrique Andreu; Felipe Prósper
Journal:  Dermatol Res Pract       Date:  2011-08-18

Review 3.  Autologous non-cultured melanocyte-keratinocyte transplantation in the treatment of vitiligo: patient selection and perspectives.

Authors:  Dalia Bassiouny; Samia Esmat
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-10-26

4.  Treatment of recalcitrant vitiligo by autologous non-cultured and trypsinized melanocyte grafting in the west of Iran.

Authors:  Iraj Ghorbani; Mozafar Khazaei; Hossein Kavoussi; Ali Ebrahimi; Mansour Rezaei; Reza Kavoussi; Kamran Mansouri
Journal:  An Bras Dermatol       Date:  2022-02-17       Impact factor: 2.113

5.  Donor to recipient ratios in the surgical treatment of vitiligo and piebaldism: a systematic review.

Authors:  V S Narayan; L L C van den Bol; N van Geel; M W Bekkenk; R M Luiten; A Wolkerstorfer
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-02-12       Impact factor: 6.166

6.  Comparison of intradermal injection of autologous epidermal cell suspension vs. spraying of these cells on dermabraded surface of skin of patients with post-burn hypopigmentation.

Authors:  Ahrari Iman; Mohamadi Ali Akbar; Khosravi Maharlooei Mohsen; Farsi Ali; Attar Armin; Ahrari Sajjad; Monabati Ahmad; Mahsa Ghavipisheh; Rahnama Leila
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

7.  Childhood vitiligo: treatment paradigms.

Authors:  Amrinder Jit Kanwar; M Sendhil Kumaran
Journal:  Indian J Dermatol       Date:  2012-11       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.